{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:04:12Z","timestamp":1792796652652,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.neurobiolaging.2008.10.012","type":"journal-article","created":{"date-parts":[[2008,12,14]],"date-time":"2008-12-14T04:27:06Z","timestamp":1229228826000},"page":"1877-1884","source":"Crossref","is-referenced-by-count":100,"title":["Soluble TNF receptors are associated with A\u03b2 metabolism and conversion to dementia in subjects with mild cognitive impairment"],"prefix":"10.1016","volume":"31","author":[{"given":"Peder","family":"Buchhave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Minthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Janciauskiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib1","first-page":"157","article-title":"Variation in serum levels of the soluble TNF receptors among healthy individuals","volume":"11","author":"Aderka","year":"1992","journal-title":"Lymphokine Cytokine Res."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neurobiolaging.2006.02.012","article-title":"Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease","volume":"28","author":"Alvarez","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib4","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III)","author":"Association","year":"1987"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00401-005-1074-9","article-title":"Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms","volume":"110","author":"Attems","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib6","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.4049\/jimmunol.135.6.3972","article-title":"Cachectin\/tumor necrosis factor: production, distribution, and metabolic fate in vivo","volume":"135","author":"Beutler","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000089137","article-title":"Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias","volume":"21","author":"Blasko","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/BF03401714","article-title":"Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia","volume":"3","author":"Botchkina","year":"1997","journal-title":"Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib10","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/WNL.38.11.1688","article-title":"A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques","volume":"38","author":"Davies","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.1995.tb01618.x","article-title":"Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis","volume":"54","author":"Diez-Ruiz","year":"1995","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib12","first-page":"1121","article-title":"The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease","volume":"115","author":"Gandy","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-8993(99)01092-6","article-title":"Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients","volume":"826","author":"Garlind","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib14","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1074\/jbc.270.13.7013","article-title":"Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43)","volume":"270","author":"Gravina","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm1202-1363","article-title":"The many faces of tumor necrosis factor in stroke","volume":"8","author":"Hallenbeck","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000100926","article-title":"Prediction of Alzheimer's disease using the CSF Abeta42\/Abeta40 ratio in patients with mild cognitive impairment","volume":"23","author":"Hansson","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib18","article-title":"Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment","author":"Hansson","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000022157","article-title":"Increased soluble tumor necrosis factor receptor levels in the serum of elderly people","volume":"46","author":"Hasegawa","year":"2000","journal-title":"Gerontology"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1083\/jcb.200705042","article-title":"Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice","volume":"178","author":"He","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2005.03.051","article-title":"Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia","volume":"383","author":"Jia","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib22","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","article-title":"Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease","volume":"25","author":"Kitazawa","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0022-1759(96)00090-7","article-title":"A comparative study of different enzyme immunosorbent assays for human tumor necrosis factor-alpha","volume":"195","author":"Kreuzer","year":"1996","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib24","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1523\/JNEUROSCI.2766-05.2005","article-title":"BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions","volume":"25","author":"Laird","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/1043-4666(90)90048-X","article-title":"Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans","volume":"2","author":"Lantz","year":"1990","journal-title":"Cytokine"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib26","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1523\/JNEUROSCI.4580-03.2004","article-title":"Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death","volume":"24","author":"Li","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib27","doi-asserted-by":"crossref","first-page":"49523","DOI":"10.1074\/jbc.M402034200","article-title":"Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway","volume":"279","author":"Liao","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib28","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","article-title":"Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies","volume":"47","author":"McGeer","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib31","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1523\/JNEUROSCI.5047-06.2007","article-title":"Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein","volume":"27","author":"Medeiros","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0531-5565(01)00191-7","article-title":"Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer's disease patients","volume":"37","author":"Paganelli","year":"2002","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-2-9","article-title":"Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease","volume":"2","author":"Patel","year":"2005","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib34","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0197-4580(01)00291-3","article-title":"The role of TNF and its receptors in Alzheimer's disease","volume":"22","author":"Perry","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jpsychires.2004.12.005","article-title":"Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?","volume":"39","author":"Richartz","year":"2005","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. Report of the NINDS\u2013AIREN International Workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib38","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1096\/fj.03-1378fje","article-title":"Gene structure and organization of the human beta-secretase (BACE) promoter","volume":"18","author":"Sambamurti","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib39","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1020568013953","article-title":"Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia","volume":"19","author":"Tarkowski","year":"1999","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib41","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1212\/WNL.54.11.2077","article-title":"TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD","volume":"54","author":"Tarkowski","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-5-2","article-title":"Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration","volume":"5","author":"Tobinick","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2003.08.028","article-title":"Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat","volume":"992","author":"Wakita","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib44","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","article-title":"Plasma Abeta(1\u201340) and Abeta(1\u201342) and the risk of dementia: a prospective case-cohort study","volume":"5","author":"van Oijen","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib45","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1111\/j.1460-9568.2005.04457.x","article-title":"Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor","volume":"22","author":"Wang","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib46","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib47","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2353\/ajpath.2007.060378","article-title":"Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice","volume":"170","author":"Yamamoto","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib48","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00406-006-0652-8","article-title":"Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia","volume":"256","author":"Yasutake","year":"2006","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib49","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","article-title":"Cerebrospinal fluid BACE1 activity in Alzheimer's disease\u2014relation to amyloid and axonal damage markers","volume":"65","author":"Zetterberg","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1022337519035","article-title":"The induction of the TNFalpha death domain signaling pathway in Alzheimer's disease brain","volume":"28","author":"Zhao","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neurobiolaging.2008.10.012_bib51","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jpsychires.2006.02.008","article-title":"Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia","volume":"41","author":"Zuliani","year":"2007","journal-title":"J. Psychiatr. Res."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458008003928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458008003928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T18:53:00Z","timestamp":1684781580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458008003928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0197458008003928"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.10.012","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}